Viscosupplementation with HANOX-M-XL (HAppyCross®) is effective in moderate hip osteoarthritis but is not an alternative to hip joint surgery in patients with severe disease. Results of a “real life” clinical survey in 191 patients. T.Conrozier; M. Bossert; A. Walliser-Lohse; M. Sondag; JC Balblanc. Eur J Musculoskeletal Dis. 2015; 2:49-55. The Read more…
1st LABRHA EUROPEAN BOARD ON VISCOSUPPLEMENTATION LYON – MAY 22-23, 2014 OBJECTIVE: Organise a meeting and invite experts from several countries of Europe to debate on the viscosupplementation use in both knee and other joints affected by osteoarthritis (OA), share experiences and propose a consensual approach as well as recommendations to Read more…
Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress by Thierry Conrozier, Pierre Mathieu, Marguerite Rinaudo, Rheumatology and Therapy, December 2014, Volume 1, Issue 1, pp 45-54; doi:10.1007/s40744-014-0001-8. – published online 25 July 2014. Abstract: Introduction Viscosupplementation by intra-articular injection of hyaluronic acid Read more…
Effect of Mannitol on Hyaluronic Acid Stability in Two in Vitro Models of Oxidative Stress by Marguerite Rinaudo, Bernard Lardy, Laurent Grange and Thierry Conrozier; Polymers 2014, 6(7), 1948-1957; doi:10.3390/polym6071948 – published online 8 July 2014. Abstract: In this paper, we propose the evaluation of the mannitol’s ability to Read more…
SECOND GENERATION VISCO-ELASTIC SOLUTION INDICATED IN THE TREATMENT OF PAIN IN SMALL JOINTS AFFECTED BY OSTEOARTHRITIS UNIQUE COMBINATION OF CROSS-LINKED HYALURONIC ACID + MANNITOL MEDICAL DEVICE – 1 x 1 ml (SINGLE INTRA-ARTICULAR INJECTION) Appropriate Volume HAppyMini® is supplied in a 1ml pre-filled syringe and is Read more…